Ligand Pharmaceuticals reported $812.07M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Acorda Therapeutics ACOR:US $ 164.48M 26.01M
Amgen AMGN:US $ 8217M 30M
Anika Therapeutics ANIK:US $ 290.06M 3.26M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
Arrowhead Research ARWR:US $ 408.82M 28.07M
Baxter International BAX:US $ 8770M 276M
Bristol Myers Squibb BMY:US $ 37213M 405M
Clovis Oncology CLVS:US $ -225.46M 18.48M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Eli Lilly And LLY:US $ 7757M 1312.6M
Enanta Pharmaceuticals ENTA:US $ 399.43M 18.42M
Endo International Ordinary Shares ENDP:US $ -690.32M 73.28M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
Gilead Sciences GILD:US $ 21471M 1768M
Glaxosmithkline GSK:US $ 15426M 49M
GlaxoSmithKline GSK:LN 15426M 49M
Harsco HSC:US $ 695.54M 2.03M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Immunogen IMGN:US $ 77.09M 8.63M
Insmed INSM:US $ 504.84M 26.21M
Intrexon XON:US $ 131.25M 27.95M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Lannett LCI:US $ -47.35M 19.88M
Ligand Pharmaceuticals LGND:US $ 812.07M 25.55M
Macrogenics MGNX:US $ 291.44M 27.61M
Pacira Pharmaceuticals PCRX:US $ 718.6M 31.43M
Rigel Pharmaceuticals RIGL:US $ 49.67M 18.44M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Spectrum Pharmaceuticals SPPI:US $ 79.46M 29.12M
Teva Pharmaceutical Industries TEVA:US $ 10467M 143M
Veracyte VCYT:US $ 1107.08M 135.9M